Enfusion, Inc.
ENFN
$10.76
-$0.04-0.37%
NYSE
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 121.00K | 1.42M | 1.83M | -539.00K | 623.00K |
| Total Depreciation and Amortization | 1.75M | 1.56M | 1.67M | 1.57M | 2.52M |
| Total Amortization of Deferred Charges | 1.56M | 1.46M | 1.26M | 1.16M | 1.08M |
| Total Other Non-Cash Items | 5.93M | 6.14M | 7.27M | 8.40M | 5.25M |
| Change in Net Operating Assets | 321.00K | 5.59M | -4.71M | -9.06M | -2.87M |
| Cash from Operations | 9.67M | 16.16M | 7.31M | 1.53M | 6.59M |
| Capital Expenditure | -891.00K | -1.10M | -1.01M | -635.00K | -1.21M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1.77M | -1.67M | -4.70M | -2.11M | -1.09M |
| Cash from Investing | -2.66M | -2.78M | -5.71M | -2.75M | -2.30M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | 19.00K | -- | 0.00 |
| Repurchase of Common Stock | 0.00 | -14.00K | -- | -1.27M | -579.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | -35.00K | -101.00K | 0.00 |
| Cash from Financing | 0.00 | -14.00K | -16.00K | -1.37M | -579.00K |
| Foreign Exchange rate Adjustments | -829.00K | 479.00K | -39.00K | -122.00K | 240.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 6.18M | 13.85M | 1.55M | -2.71M | 3.95M |